Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design
-
Published:2021-10
Issue:10
Volume:6
Page:2575-2584
-
ISSN:2468-0249
-
Container-title:Kidney International Reports
-
language:en
-
Short-container-title:Kidney International Reports
Author:
Walsh Liron,
Reilly John F.,
Cornwall Caitlin,
Gaich Gregory A.,
Gipson Debbie S.,
Heerspink Hiddo J.L.ORCID,
Johnson Leslie,
Trachtman Howard,
Tuttle Katherine R.ORCID,
Farag Youssef M.K.,
Padmanabhan Krishna,
Pan-Zhou Xin-Ru,
Woodworth James R.,
Czerwiec Frank S.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献